ITHA:NASDAQITHAX Acquisition Corp III Analysis
Data as of 2026-04-11 - not real-time
$9.90
Latest Price
8/10Risk
Risk Level: High
Executive Summary
ITHAX Acquisition Corp III (ITHA) remains a pure SPAC vehicle with no operating revenue, negative book value per share, and a modest debt load, indicating that the current market price is not supported by underlying assets. Technical metrics show the short‑term, medium‑term, and long‑term moving averages essentially flat and converging, an RSI hovering around the neutral midpoint, and a MACD histogram that has just turned positive, suggesting only a faint bullish tilt. However, trading volume is extremely low and trending downward, while the broader market sentiment is in an Extreme Greed phase, which may be inflating price without fundamentals to justify it.
Given the absence of earnings, the negative price‑to‑book ratio, and the liquidity constraints, the stock appears overvalued and carries significant downside risk. Investors should treat ITHA as a high‑risk speculative play, with any upside hinging on the successful completion of a merger or acquisition, which remains uncertain at this stage.
Given the absence of earnings, the negative price‑to‑book ratio, and the liquidity constraints, the stock appears overvalued and carries significant downside risk. Investors should treat ITHA as a high‑risk speculative play, with any upside hinging on the successful completion of a merger or acquisition, which remains uncertain at this stage.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- extremely low and decreasing trading volume
- absence of revenue or earnings
- price unsupported by negative book value
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- potential upside if a merger is announced
- still overvalued relative to assets
- moderate sector and regulatory risk
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- outcome of a future business combination is the primary catalyst
- current fundamentals remain nonexistent
- high liquidity risk may persist
Key Metrics & Analysis
Financial Health
P/B Ratio-8.6
Industry P/E17.1
Technical Analysis
TrendNeutral
RSI48.4
Support$9.86
Resistance$9.91
MA 20$9.89
MA 50$9.90
MA 200$9.90
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta-0.02
Volatility1.49%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.